Lilly Ventures Fund I LLC 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2020-06-08 4:04 pm Sale |
2020-05-11 | 13D | Protagonist Therapeutics, Inc. PTGX |
Lilly Ventures Fund I LLC | 1,559,060 4.500% |
-540,422![]() (-25.74%) |
Filing |